CoDiagnostics (CODX)
(Delayed Data from NSDQ)
$1.17 USD
+0.02 (1.74%)
Updated Aug 13, 2024 04:00 PM ET
After-Market: $1.16 -0.01 (-0.85%) 7:58 PM ET
3-Hold of 5 3
F Value C Growth D Momentum F VGM
Price, Consensus and EPS Surprise
CODX 1.17 +0.02(1.74%)
Will CODX be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for CODX based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for CODX
Co-Diagnostics, Inc. (CODX) Reports Q2 Loss, Tops Revenue Estimates
GeneDx Holdings Corp. (WGS) Reports Q2 Loss, Tops Revenue Estimates
CODX: What are Zacks experts saying now?
Zacks Private Portfolio Services
Icon PLC (ICLR) Q2 Earnings Surpass Estimates
Elevance Health (ELV) Beats Q1 Earnings Estimates
Icon PLC (ICLR) Q4 Earnings Surpass Estimates
Other News for CODX
UK shareholder meetings calendar - next 21 days
UK shareholder meetings calendar - next 7 days
UK shareholder meetings calendar - next 21 days
UK shareholder meetings calendar - next 7 days
Hold Rating Maintained for Co-Diagnostics Amidst Revenue Growth and Development Progress